Jeffrey Robert Ajer - Mar 15, 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: EVP, Chief Commercial Officer
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Stock symbol: BMRN
Transactions as of: Mar 15, 2023
Transactions value $: -$2,264,255
Form type: 4
Date filed: 3/17/2023, 09:16 PM
Previous filing: Mar 2, 2023
Next filing: Aug 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$0	+10.1K	+12.66%	$0.00	90K	Mar 15, 2023	Direct	F1
transaction	BMRN	Common Stock	Tax liability	-$348K	-3.97K	-4.41%	$87.74	86K	Mar 15, 2023	Direct
transaction	BMRN	Common Stock	Tax liability	-$1.92M	-20.5K	-23.85%	$93.41	65.5K	Mar 16, 2023	Direct

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Award	$0	+23.1K		$0.00	23.1K	Mar 15, 2023	Common Stock	23.1K	$87.74	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on March 15, 2023. Price not applicable.
F2	Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.